Immunotoxicology IV - innovative methods and applications for risk assessment in pharmaceutical development: introduction to the conference.
House
Robert V
RV
DynPort Vaccine Company LLC, Frederick, Maryland 21702, USA. rhouse2@csc.com
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001688:Biological Products / Q000008:administration & dosage* / Q000009:adverse effects* / Q000276:immunology; D015415:Biomarkers / Q000032:analysis / Q000378:metabolism; D002626:Chemistry, Pharmaceutical / Q000639:trends; D016207:Cytokines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015195:Drug Design; D006801:Humans; D007114:Immunization / Q000009:adverse effects*; D007167:Immunotherapy / Q000009:adverse effects; D051379:Mice; D023421:Models, Animal; D015213:Neuroimmunomodulation; D011323:Primates; D051381:Rats; D018570:Risk Assessment / Q000379:methods / Q000706:statistics & numerical data / Q000639:trends; D013312:Stress, Physiological / Q000276:immunology
D000911:Antibodies, Monoclonal; D001688:Biological Products; D015415:Biomarkers; D016207:Cytokines